Cite
[Metastatic renal cell carcinoma: Management of toxicities of combinations].
MLA
Joly, Florence, et al. “[Metastatic Renal Cell Carcinoma: Management of Toxicities of Combinations].” Bulletin Du Cancer, vol. 109, no. 7–8, July 2022, pp. 844–61. EBSCOhost, https://doi.org/10.1016/j.bulcan.2022.04.019.
APA
Joly, F., Michot, J.-M., Dourthe, L. M., Fléchon, A., Mahammedi, H., Maillet, D., Mouillet, G., Pouessel, D., Rolland, F., Topart, D., & Albiges, L. (2022). [Metastatic renal cell carcinoma: Management of toxicities of combinations]. Bulletin Du Cancer, 109(7–8), 844–861. https://doi.org/10.1016/j.bulcan.2022.04.019
Chicago
Joly, Florence, Jean-Marie Michot, Louis Marie Dourthe, Aude Fléchon, Hakim Mahammedi, Denis Maillet, Guillaume Mouillet, et al. 2022. “[Metastatic Renal Cell Carcinoma: Management of Toxicities of Combinations].” Bulletin Du Cancer 109 (7–8): 844–61. doi:10.1016/j.bulcan.2022.04.019.